4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-010474
CHIEF OPERATING OFFICER sold 6,667 shares at an average $18.04 ($120,269)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-07 | Sale : show line 1 in the form 10b5-1 | −3,756 | $17.81 | $66,889 | 319,554 | I |
| 2025-04-07 | Sale : show line 2 in the form 10b5-1 | −2,763 | $18.29 | $50,527 | 316,791 | I |
| 2025-04-07 | Sale : show line 3 in the form 10b5-1 | −148 | $19.27 | $2,852 | 316,643 | I |
| Open-market sales · 6,667 sh · avg $18.04 · $120,269 | ||||||
Loading xslF345X05/form4-04092025_080436.xml…